Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Tian‐Lan Tang"'
Autor:
Cheng Huang, Tian-Lan Tang, Yan-Yan Qiu, Yu-Ping Lin, Si-Lin Chen, Rui-Zhi Zhao, Gui-Qing Shi, Si-Qin Liao, Jin-Hua Chen, Hai-Ying Fu, Jian-Zhi Liu, Ben-Hua Xu, Ting-Bo Liu, Yong Yang
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Radiotherapy (RT) is an effective and available local treatment for patients with refractory or relapsed (R/R) aggressive B-cell lymphomas. However, the value of hypofractionated RT in this setting has not been confirmed. Methods
Externí odkaz:
https://doaj.org/article/1c835e0171144cb98d6b06bc42b8a231
Autor:
Yong Yang, Ji‐Jin Wang, Rui‐Zhi Zhao, Cheng Huang, Gui‐Qing Shi, Hao Zheng, Tian‐Lan Tang, Si‐Qin Liao, Jin‐Hua Chen, Jian‐Zhen Shen, Ting‐Bo Liu, Ben‐Hua Xu, Yu‐Jing Zhang
Publikováno v:
CancerREFERENCES. 128(22)
Limited evidence supports the omission of routine bone marrow (BM) examination (biopsy and aspiration) in patients with nasal-type extranodal NK/T-cell lymphoma (ENKTCL). This study was aimed at assessing whether BM examination provides valuable info
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e4ace06dabe33cdd91172375250a0c2
https://pubmed.ncbi.nlm.nih.gov/36181669
https://pubmed.ncbi.nlm.nih.gov/36181669
Autor:
Ben-Hua, Xu, Pan, Chi, Jin-Hua, Guo, Guo-Xian, Guan, Tian-Lan, Tang, Ying-Hong, Yang, Ming-Qiu, Chen, Jian-Yuan, Song, Chang-Yin, Feng
Publikováno v:
Tumori Journal. 100:149-157
Aims and Background Locally advanced rectal adenocarcinoma is typically treated with neoadjuvant chemoradiotherapy and surgery. We assessed the effect of an additional cycle of capecitabine/oxaliplatin chemotherapy before surgery in 57 patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7efef58998d3b19e2429ecebb55df004
https://doi.org/10.1177/030089161410000206
https://doi.org/10.1177/030089161410000206
Autor:
Tian-Lan Tang, Zhicao Yue, Yuyan Guo, Pan Chi, Haijie Lu, Chi Lin, Yuangui Chen, Guoxian Guan, Benhua Xu
Publikováno v:
Radiation Oncology (London, England)
Background The small bowel (SB) represents the most important dose-limiting structure in pelvic radiotherapy (RT). However, we observed that the majority of rectal cancer patients who received preoperative pelvic intensity modulated RT (IMRT) develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f9edf1a3c610dcc4ad48cbc3f97db87
http://europepmc.org/articles/PMC4683870
http://europepmc.org/articles/PMC4683870